Pulmonary artery occlusion pressure may overdiagnose pulmonary artery hypertension in sickle cell disease

Clinical Cardiology

Volumn 36, Issue 9, 2013, Pages 524-530

  Sharma, Sunil ^a   Efird, Jimmy ^b   Kadali, Renuka ^b   Mehra, Sanjay ^b   Chohan, Hadi ^b   Daggubati, Ramesh ^b   Liles, Darla ^b   Gouge, Catherine ^b   Boettger, Peter ^b   Knupp, Charles ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HEART CATHETERIZATION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PROSPECTIVE STUDY; PULMONARY ARTERY OCCLUSION PRESSURE; PULMONARY HYPERTENSION; SICKLE CELL ANEMIA; TRICUSPID VALVE REGURGITATION; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADULT; AGED; ANEMIA, SICKLE CELL; CARDIAC CATHETERIZATION; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY WEDGE PRESSURE; VENTRICULAR PRESSURE; YOUNG ADULT;

EID: 84883885280     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22153     Document Type: Article

References (28)

1. Haque AK, Gokhale S, Rampy BA, Adegboyega P, Duarte A, Saldana MJ,. Pulmonary hypertension in sickle cell hemoglobinopathy: A clinicopathologic study of 20 cases. Hum Pathol. 2002; 33: 1037-1043.
2. Sutton LL, Castro O, Cross DJ, Spencer JE, Lewis JF,. Pulmonary hypertension in sickle cell disease. Am J Cardiol. 1994; 74: 626-628.
3. Castro O., Systemic fat embolism and pulmonary hypertension in sickle cell disease. Hematol Oncol Clin North Am. 1996; 10: 1289-1303.
4. Powars D, Weidman JA, Odom-Maryon T, Niland JC, Johnson C,. Sickle cell chronic lung disease: Prior morbidity and the risk of pulmonary failure. Medicine (Baltimore). 1988; 67: 66-76.
5. Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, Minter K, Brown B, Coles WA, Nichols JS, Ernst I, Hunter LA, Blackwelder WC, Schechter AN, Rodgers GP, Castro O, Ognibene FP,. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med. 2004; 350: 886-895.
6. Ataga KI, Moore CG, Jones S, Olajide O, Strayhorn D, Hinderliter A, Orringer EP,. Pulmonary hypertension in patients with sickle cell disease: A longitudinal study. Br J Haematol. 2006; 134: 109-115.
7. Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G,. Guidelines for the diagnosis and treatment of pulmonary hypertension: The task force for the diagnosis and treatment of pulmonary hypertension of the european society of cardiology (ESC) and the european respiratory society (ERS), endorsed by the international society of heart and lung transplantation (ISHLT). Eur Heart J. 2009; 30: 2493-2537.
8. Machado RF, Mack AK, Martyr S, Barnett C, Macarthur P, Sachdev V, Ernst I, Hunter LA, Coles WA, Nichols JP, Kato GJ, Gladwin MT,. Severity of pulmonary hypertension during vaso-occlusive pain crisis and exercise in patients with sickle cell disease. Br J Haematol. 2007; 136: 319-325.
9. Parent F, Bachir D, Inamo J, A hemodynamic study of pulmonary hypertension in sickle cell disease. A hemodynamic study of pulmonary hypertension in sickle cell disease. N Engl J Med. 2011; 365: 44-53.
10. Hachulla E, Gressin V, Guillevin L, Carpentier P, Diot E, Sibilia J, Kahan A, Cabane J, Francès C, Launay D, Mouthon L, Allanore Y, Tiev KP, Clerson P, de Groote P, Humbert M,. Early detection of pulmonary arterial hypertension in systemic sclerosis: A french nationwide prospective multicenter study. Arthritis Rheum. 2005; 52: 3792-3800.
11. Anthi A, Machado RF, Jison ML, Taveira-Dasilva AM, Rubin LJ, Hunter L, Hunter CJ, Coles W, Nichols J, Avila NA, Sachdev V, Chen CC, Gladwin MT,. Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension. Am J Respir Crit Care Med. 2007; 175: 1272-1279.
12. Sachdev V, Machado RF, Shizukuda Y, Rao YN, Sidenko S, Ernst I, St Peter M, Coles WA, Rosing DR, Blackwelder WC, Castro O, Kato GJ, Gladwin MT,. Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease. J Am Coll Cardiol. 2007; 49: 472-479.
13. Halpern SD, Taichman DB,. Misclassification of pulmonary hypertension due to reliance on pulmonary capillary wedge pressure rather than left ventricular end-diastolic pressure. Chest. 2009; 136: 37-43.
14. Soto FJ,. Pulmonary venous hypertension: A diagnostic and therapeutic dilemma. Advances in Pulmonary Hypertension. Winter 2007; 6: 168-174. Available from: http://www.phaonlineuniv.org/Journal/Vol6No4Winter07/ PulmonaryVenousHypertension. Accessed 11/6/2001.
15. Oudiz RJ,. Pulmonary hypertension associated with left-sided heart disease. Clin Chest Med. 2007; 28: 233-41.
16. Benza RL, Tallaj JA,. Pulmonary hypertension out of proportion to left heart disease. Advances in Pulmonary Hypertension. Spring 2006; 5: 21-29. Available from: http://www.phaonlineuniv.org/Journal/Vol5No1Spring06/ PHandLeftHeartDisease. Accessed 11/6/2011.
17. Standardization of spirometry, 1994 update. American Thoracic Society. Am J Respir Crit Care Med. 1995; 152: 1107-1136.
18. American thoracic society. single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique - 1995 update. Am J Respir Crit Care Med. 1995; 152: 2185-2198.
19. Brooks D, Solway S, Gibbons WJ,. ATS statement on six-minute walk test. Am J Respir Crit Care Med. 2003; 167: 1287.
20. Machado RF, Anthi A, Steinberg MH, Bonds D, Sachdev V, Kato GJ, Taveira-DaSilva AM, Ballas SK, Blackwelder W, Xu X, Hunter L, Barton B, Waclawiw M, Castro O, Gladwin MT; N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease. JAMA. 2006; 296: 310-318.
21. Mekontso Dessap A, Leon R, Habibi A, Nzouakou R, Roudot-Thoraval F, Adnot S, Godeau B, Galacteros F, Brun-Buisson C, Brochard L, Maitre B,. Pulmonary hypertension and cor pulmonale during severe acute chest syndrome in sickle cell disease. Am J Respir Crit Care Med. 2008; 177: 646-653.
22. Machado RF, Barst RJ, Yovetich NA, Hassell KL, Kato GJ, Gordeuk VR, Gibbs JS, Little JA, Schraufnagel DE, Krishnamurti L, Girgis RE, Morris CR, Rosenzweig EB, Badesch DB, Lanzkron S, Onyekwere O, Castro OL, Sachdev V, Waclawiw MA, Woolson R, Goldsmith JC, Gladwin MT,. Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity. Blood. 2011; 118: 855-864.
23. Mehari A, Gladwin MT, Tian X, Machado RF, Kato GJ,. Mortality in adults with sickle cell disease and pulmonary hypertension. JAMA. 2012 Mar 28; 307: 1254-1256.
24. Fonseca GH, Souza R, Salemi VM, Jardim CV, Gualandro SF,. Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease. Eur Respir J. 2012; 39: 112-118.
25. Ryan JJ, Rich JD, Thiruvoipati T, Swamy R, Kim GH, Rich S,. Current practice for determining pulmonary capillary wedge pressure predisposes to serious errors in the classification of patients with pulmonary hypertension. Am Heart J. 2012 Apr; 163 (4): 589-594
26. Walston, A, Kendall E,. Comparison of pulmonary wedge and left atrial pressure in man. American Heart Journal. 1973: 159-164.
27. Pinsky MR,. Clinical significance of pulmonary artery occlusion pressure. Intensive Care Med. 2003; 29 (2): 175-178.
28. Miller AC, Gladwin MT,. Pulmonary complications of sickle cell disease. Am J Respir Crit Care Med Vol 185, Iss. 11, pp 1154-1165, Jun 1, 2012